Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Glinides / Meglitinides & Type 2 diabetes (T2D)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Glinides / Meglitinides) are rapid-acting oral antidiabetic agents approved for type 2 diabetes treatment that stimulate insulin secretion from pancreatic beta cells to lower blood glucose, particularly targeting postprandial hyperglycemia.
Guardado-Mendoza et al. 2013 Arch Med Sci 9(5): 936-43
Landgraf 2000 Drugs Aging 17(5): 411-25

Considered are

Meglitinide analogues in the treatment of type 2 diabetes mellitus
Landgraf 2000 Drugs Aging 17(5): 411-25
Review
The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus
Guardado-Mendoza et al. 2013 Arch Med Sci 9(5): 936-43

7/1/2026